• infertilityFacebook
  • infertilitySearch
  • infertilityForum
  • infertilityTwitter




Patient Forms

You must have the free Adobe Reader to view these forms. Get Adobe Reader.

New Patients - These forms will be requested prior to your first visit.

 

 

 

 

 

 

 

Office Policies

Welcome and thank you for choosing the Institute for Human Reproduction for your treatment. Below is our office policies and procedures to ensure that you receive the best care and treatment as possible. If you have any questions regarding these policies, please feel free to ask any of the staff for assistance. If you have any suggestions that may assist you or future patients with their treatment in our office, please bring them to the attention of the office manager. Good luck with your treatment.

Office Hours

Our office is open from 8:00 AM to 5:00 PM on Monday thru Friday. Patients are seen on the weekend only during treatments. No routine visits will be scheduled on the weekend.

Phone Calls

Our telephone is answered by our staff with an automated system backup to give you, the patient, the fastest access to our staff. There are options for appointment scheduling, billing/insurance and the nurses. All staff has voice mail availability if they are unable to answer their phone. The nurses will answer the phone unless they are assisting the physician or on the phone with another patient. The nurse's voicemail is available 24 hours should you want to call and leave your message after hours. The voice mail will be accessed the next business day. Our IVF nurse is on call every evening and weekend until 10:00PM for urgent calls. There is a physician on call 24 hours for medical emergencies.

Missed and cancelled appointments

If you are unable to make a scheduled appointment, please cancel with our office with at least 24 hours notice. This gives our office the opportunity to offer that appointment time to another patient.

Insurance

IHR is contracted with most major insurance companies. Our office will file for all covered procedures on any plan that IHR is contracted with. If IHR is not contracted with your insurance company, you may have what is called “out of network benefits” that will cover a lower portion of our fees. Be sure and discuss your insurance plan with our billing/insurance office regarding your out-of-pocket expenses. Unless we have written verification of Infertility coverage, you will be required to pay all Infertility procedures/treatments at the time of service. For written verification you may send a predetermination letter to your insurance company or bring in a copy of your individual plan. If insurance has not paid a claim in 90 days, it will become the responsibility of the insured. You are the insured and a consumer and have the right and authority to contact your insurance company and appeal denials. Sometimes a complaint from the actual insured will move the payment process along more expediently. You may contact our billing/insurance office for any assistance or questions you may have in appealing an insurance claim. If you have a question about fees, please call our billing/insurance office for assistance.

Infertility Financing

Infertility Financing

The Institute for Human Reproduction (IHR) wants to make achieving your dreams of parenthood the most manageable and convenient possible. We have partnered with a global financing leader to administer loan transactions for IHR’s Infertility Program participants.

Fertility financing options include: easy no-cost, online application process, no initial payment, no prepayment penalty and secured loans with preferred discount rates. All fertility and IVF financing is at the sole discretion of and subject to the lending institution's credit approval. Click here, to learn more about IHR’s Infertility Financing.

Diseases & Conditions

Endometriosis

Endometriosis occurs when tissue like that lines the inside of the uterus grows outside the uterus. The two most common symptoms, pain and infertility, can deeply affect a woman's quality of life. In many cases, women who receive treatment for their endometriosis pain are able to get pregnant. But this is not the case for all women. Researchers estimate that nearly 5.5 million women in North America have endometriosis. Endometriosis is not a cancerous condition. Also, current research does not prove an association between endometriosis and uterine, cervical, endometrial, or ovarian cancers. For more information on endometriosis.

Polycystic Ovary Syndrome (PCOS)

PCOS is one of the most common causes of female infertility. PCOS is a condition in which a woman’s ovaries and, in some cases the adrenal glands, produce more androgens (a type of hormone) than normal. High levels of these hormones interfere with the development and release of eggs as part of ovulation. As a result, fluid-filled sacs or cysts can develop on the ovaries. Researchers estimate that 5 percent to 10 percent of women in the United States have PCOS. Research shows that women with PCOS are also at higher risk than women without the disorder to experience other health problems, such as insulin resistance, obesity, high blood pressure, and heart disease. Although researchers are still trying to learn about this disease, and to find ways to treat the infertility associated with PCOS, there have been some promising leads. One group of researchers may have found a possible treatment for the infertility related to PCOS. For more information about PCOS.

Premature Ovarian Failure (POF)/Primary Ovarian Insufficiency (POI)

Health care providers use the terms POF or POI to describe a stop in normal functioning of the ovaries in a woman under the age of 40. (Women's ovary function naturally begins to decline at age 40). In POF, the ovaries stop making eggs and stop making certain hormones. An estimated 250,000 women under age 40 have POF in the United States. Health care providers used to call this condition premature menopause, but premature ovarian failure is actually much different than menopause. For more information on POF/POI.

Uterine Fibroids

Uterine fibroids are the most common, non-cancerous tumors in women of childbearing age. These tumors are made of muscle cells and other tissues that grow within the wall of the uterus. Uterine fibroids are the cause of more than 200,000 hysterectomies each year. Uterine fibroids are not cancerous, nor are they associated with cancer. In very rare instances, less than 0.1 percent of cases, fibroids do develop into cancer. For more information about uterine fibroids.

Multimedia Library

IHR provides free videos, articles and audio on infertility and how infertility can be treated. Topics include ovary transplant surgery, vasectomy reversal, in vitro fertilization (IVF), fertility preservation options and much more. IHR offers many different treatments for both male and female infertility.

Below are Video clips and audio excerpts on infertility science and treatment

 

 

 

 

 

 

 

 

 

 

Infertility Publication

IHR experts are continuing to advance the field of infertility

Below are listing of IHR infertility publications

1. Munne S, Cohen J, Gianaroli L, Tur-Kaspa I, Magli C, Sandalinas M, Grifo J, Verlinsky Y Simpson JL Embryo Damage by Sub-optimal Biopsy may interfere with clinical success of PGD for infertility.Fertil Steril, 2007
2. Verlinsky Y, Tur-Kaspa I, Cieslak J, Bernal A, Morris R, Taranissi M, Kaplan B, Kuliev A PGD for chromosomal disorders improves reproductive outcome. Reproductive BioMedicine Online, 2005; Vol 2, Number 2 219-225.
3. Rechitsky S, Kuliev A, Tur-Kaspa I, Morris R, Verlinsky Y. Preimplantation genetic diagnosis with HLA matching. Reprod BioMedicine Online, 2004; 9:210-221.
4. Tur-Kaspa I, Shmuel S, Federica M, Massobrio M, Meltzer S Viagra during treatments with assisted reproductive technologies Reproductive BioMedicine Online, 2005; Vol 2, Number 2 210-221.
5. Rechitsky S, Kuliev, Tur-Kaspa I, Morris R, Verlinsky Y Guanylate Cyclase Activity and Sperm Function Endocrine Reviews, 2002; Vol 23, Number 4 484-494.
6. Revelli, A, Tur-Kaspa I, Holte JG, Massobrio M Biotechnology of Human Reproduction New York, The Parthenon Publishing Group, 2003
7. Granat M, Tur-Kaspa I, Zylber-Katz E, Shenker JG Inhibition of peritoneal adhesion formation by colchicine. In: Diagnosis and management of tubo-uterine factors in infertility. MTP Press Limited, International Medical Publishers, 1983, 199-202.
8. Tur-Kaspa I, Gleicher N. Immunology of the uterus. In: Altcheck A, Deligdisch L, eds. The Uterus. New York, Springer-Verlag Publishers, 1991, 27-38
9. Tur-Kaspa I, Gleicher N. Disorders of connective tissue. In: Gleicher N, ed. Principles of medical therapy in pregnancy. East Norwalk, Appleton & Lange, 1991, 277-80.
10. Tur-Kaspa I, Gleicher N. Disorders of the hypothalamus and pituitary. In: Gleicher N, ed. Principles of medical therapy in pregnancy. East Norwalk, Appleton & Lange, 1991, 314-321.
11. Tur-Kaspa I, Neuman AM. Abnormal hormone production. In: Gleicher N, ed. Principles of medical therapy in pregnancy. East Norwalk, Appleton & Lange, 1991, 381-83.
12. Tur-Kaspa I. Pathophysiology of the fallopian tube. In: Gleicher N, ed. Tubal catheterization. New York, Wiley-Liss, Inc. 1992, 5-14.
13. Eisenbach M, Manor M, Tur-Kaspa I, Cohen-Dayag A, Goldenberg M, Yuli I, Makler A, Dor J, Mashiach S, Garbers D L, Ralt D., Mammalian sperm chemotaxis. In: Oshima H, Burger HG, eds. Current topics in andrology. Japan Society of Andrology, 1993, 250-55.
14. Moran.D, Cohen A, Ashkenazy S,. Albukrek D, Tur-Kaspa I. Determining tolerance time in encapsulated rooms - physiological consideration. In: Shapiro Y, Moran DS, Epstein Y, eds. Environmental Ergonomics: recent progress and new frontiers Tel Aviv, Freund Publishing House Ltd. 1996, 241-44.
15. Tur-Kaspa I, Paz I, Gleicher N. Disorders of the pituitary and hypothalamus. In: Gleicher N, ed. Principles & practice of medical therapy in pregnancy. East Norwalk, Appleton & Lange, 1998, 424-32.
16. Paz I, Tur-Kaspa I. Abnormal hormone production. In: Gleicher N, ed. Principles & practice of medical therapy in pregnancy. East Norwalk, Appleton & Lange, 1998, 474-78.
17. Tur-Kaspa I, Shalgi R, Kaplan-Kraitzer R, Eskaraev R, Segal S, Inbal A. A possible role for Factor XIII in preventing early pregnancy loss. In: Proceeding of the 11th World Congress on In Vitro Fertilization and Human Reproductive Genetics Monduzzi Editore, Bologna, 1999:389-94.
18. Tur-Kaspa I. Transcervical tubal catheterization (TTC) - The procedure of choice in the management of infertile women with proximal tubal occlusion. In: Seidman DS, ed. Operative Gynecologic Endoscopy. Petach-Tikva, Offset Color Ltd., 2000.
19. Revelli A, Poso F, Tur-Kaspa I. New insights on gametogenesis, sperm migration, fertilization and embryo implantation in humans. In: Revelli, A, Tur-Kaspa I, Holte JG, Massobrio M, eds. Biotechnology of Human Reproduction. New York: The Parthenon Publishing Group, 2003:9-42.
20. Tur-Kaspa I. Modern techniques for the diagnosis and treatment of tubal occlusion. In: Revelli, A, Tur-Kaspa I, Holte JG, Massobrio M, eds. Biotechnology of Human Reproduction New York: The Parthenon Publishing Group, 2003:353-61.
21. Tur-Kaspa I, Segal S, Zohav E. The ART of imaging: Three dimensional (3D) ultrasound and ART. In: Revelli, A, Tur-Kaspa I, Holte JG, Massobrio M, eds. Biotechnology of Human Reproduction. New York: The Parthenon Publishing Group, 2003:363-73.
22. Tur-Kaspa I. Transcervical Tubal Evaluation In: Desai S, Parihar M, Allahbadia G, eds. Updates on Infertility. New Delhi: B.I. Publications Pvt Ltd, 2004: 44-50.
23. Tur-Kaspa I, Segal S, Zohav E. 3D ultrasound and infertility. In: Desai S, Parihar M, Allahbadia G, eds. Updates on Infertility. New Delhi: B.I. Publications Pvt Ltd, 2004: 310-18.
24. Tur-Kaspa I, Bahat A, Eisenbach M. The Role of Chemotaxis and Thermotaxis in Human Reproduction. In: Allahbadia G, Saridogan E, Ddjahanbakhch O, eds. The Fallopian Tube. Kent, UK. Anshan Ltd, 2009: 92-101.
25. Confino E, Tur-Kaspa I Minimally Invasive Imaging Procedures for Tubal Infertility. In: Allahbadia G, Saridogan E, Ddjahanbakhch O, eds. The Fallopian Tube Kent, UK. Anshan Ltd, 2009: 246-55.

 

 

 

 

 

 

 

 

 

 

Patient Testimonials

Here is a sample of the patient commentary we receive at the Institute for Human Reproduction. If you would like to send us a brief summary of your experience, please send us an e-mail. Include a photo, too, if you'd like!



We wanted to send you a note to share our joyful news - Kate was born on June 14th weighing 8lbs., 7oz. and measuring 20.5"! She is a beautiful, healthy baby and everyone here is doing great! We would not have our precious baby with us today if it was not for you - thank you from the bottom of our hearts!!! We will be seeing you again in 2 years for a repeat performance!
Sincerely, the Proud Parents of Kate



I read and compared many centers over the internet and every person who had been successful went to RGI-IHR. That’s why we chose your facility. It was a great and I continue to refer people to you in support groups of people who are in the same situation as we are. Thank you!!! We will continue to refer you to others.



Outstanding experience. The nursing and physician staff were outstanding. Highly recommend. They are one stop shopping from the IVF to the post pregnacy genetic testing to outstanding genetic consulting. Everything is offered in one location. Their experience and knowledge is vast. They made my experience as an busy surgeon great. I was also out of state and they worked with me in all aspects of my schedule and travel. They were very easy to contact via phone during and after business hours. Their caring additude and wealth of knowledge was great. They were the third program I had used and we were successful in producing a baby boy. They offered the state of the art technology which resulted in our success. Their amount of volume and experience was so valuable. They are one of the US/world leading centers in PGD which is what initially attracted me to their center. Each step of the way was just as good has their world wide PGD reputation: from my telephone interview with Dr. Tur Kaspa to my daily telephone dealings with his outstanding nursing/MD staff to the painless egg retrieval/transfer and the final CVS .
Thank you!!! Mom of a healthy baby boy


Thank you very much for your professional and first class care. Love,the Proud Parents of a healthy baby



Our little boy has finally arrived. We are very proud, happy and sleep deprived, We can't thank all of you enough. IVF parents, Indiana


Thank you for helping us realize our dream. Parents of a healthy baby girl, Michigan


Thank you all for everything you have done for us. You have given us two perfectly healthy baby boys. Words can't express our thanks.
New parents of twin boys, Iowa




You have been so kind, so professional, so wonderful that words could never explain my gratitude. I appreciate all your calls and answering my questions, etc. Thank you so very much.
Sincerely, a patient, Chicago, IL


We want to thank you for all you did for us. Your support and encouragement helped us through this trying time in our life. With your help we were able to give birth to two healthy little boys! We hope to one day be able to say thank you in person.
With much gratitude, IVF patient, New York, NY


We are overjoyed with our miracle baby - born healthy with the help of PGD and IVF. She is just perfect and we couldn't be happier! Wishing you all the best and lots of thanks, IVF patients, Chicago, IL


Thank you again for all your help. Your clinic has truly been a miracle for us! Parents of a healthy baby born from PGD, Wichita, KS


We want to thank you so much for all your help and support while we were in Chicago. You really helped us a lot and we appreciate it so much. We are doing fine and will let you know when the good news arrives!! Stay well and all the best! Thank you again! A Pregnant patient


We wanted you to know how much we appreciated everything you did for us through the entire IVF process. With your help, we now have a beautiful son. He is such a blessing and a gift to our family. Thank you for being such a professional and for being such a wonderful genetic counselor. Parents of a healthy baby born, Indianapolis, IN


I just wanted to write you and thank you for all of your help during our IVF cycle. It was successful and I became pregnant with twins and had two beautiful baby girls! They are both healthy and we couldn't be happier. You were so very helpful in our meeting with you and on the phone numerous times. You always took the time to answer my questions and you always seemed very happy to help. You honestly made one of the most stressful experiences of my life a lot easier to get through. I thank you so much for your help. You have honestly helped make our dream come true! Thank you A former aneuploidy patient and proud mother of twin girls, Chicago, IL

IHR News

On this page find out what’s new in Infertility and what’s happening at IHR. We post updates on happenings, events, press clippings, video coverage and IHR-related activities that may be of interest to patients, the media, and professional colleagues.

August 15, 2010 Awarded ASRM Star Award

The Star Award is given to ASRM members, nominated by their peers, who have continuously contributed 10 or more years in reproductive field.
   
March 8, 2007 Testing Embryos for Diseases (ABC News)

How far would you go to prevent passing a deadly disease on to your children?

 

 

 

 

 

 

 

 

 

 

Billing

IHR offers a variety of Financial Options and Insurance Carriers

While you are in IHR care, we want to provide you with the highest quality of care available in a compassionate and cost effective manner. Our fertility treatment programs are structured to encourage a high level of personal contact with your medical and financial team and we encourage you to utilize these resources.

The extent of coverage, benefits, referral and authorization process vary from policy to policy. It is important that you understand what is covered before you begin treatment, or what the necessary requirements are in order to get the maximum reimbursement. The finance department can provide some general guidelines on most common policies within each plan, but ultimately it is your responsibility to understand your infertility treatment coverage under your plan.

Our billing/insurance team will be able to answer any questions regarding fee schedules, insurance issues, payment options, etc. Please feel free to contact us at 773.472.4949.

Useful Links

The Institute for Human Reproduction receives correspondence from around the world. We will consider adding your link to our website in exchange for being listed on yours. To arrange, please contact us.

The following websites have listed us on their website: